Furthermore, we previously reported on a similar CD62L− subset differentiated from naive CD4+ T-cell [63] which were hypothesised to results from exposure to IL6 (amplified by IL2/TNF) [58], with clinical significance in relation to the progression of RA from preclinical and early inflammatory stages [59, 64, 65]. The gene discussed is IL6; the disease is rheumatoid arthritis.